OtoNexus Medical Technologies key facts
as of Oct 2026- Developer of a medical device designed to diagnose middle ear infections in children and adults.
- OtoNexus Medical Technologies is valued at approximately $44.2M as of Oct 2026 (last reported valuation).
- It has raised $46.1M across 5 recorded rounds; the latest was Debt ($12.9M) in Oct 2022.
- Notable investors include US National Science Foundation, Impact Assets, MedTech Innovator, Keiretsu Forum, Catalytic Impact Foundation — 43 tracked in total.
- OtoNexus Medical Technologies has filed 10 Form Ds with the SEC since 2015, most recently Feb 2024 ($12.9M sold to 114 investors).
- Status: Privately Held (backing).
OtoNexus Medical Technologies's last reported valuation, Oct 2021. Nothing priced has surfaced since.
- ·The complete investor list: 43 names
- ·Watch OtoNexus Medical Technologies: the Monday email on marks, rounds and moves
OtoNexus Medical Technologies funding rounds
5 roundsWho backs OtoNexus Medical Technologies
43+OtoNexus Medical Technologies valuation
OtoNexus Medical Technologies's last reported valuation was $44.2 million in Oct 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has OtoNexus Medical Technologies raised?
OtoNexus Medical Technologies has raised $46.1 million across 5 recorded rounds since 2015. The largest was a $7.8 million early-stage round in Dec 2016; the most recent was a $12.9 million debt round in Oct 2022.
OtoNexus Medical Technologies has filed 10 Form Ds with the SEC since 2015, most recently in Feb 2024 ($12.9 million sold to 114 investors).
OtoNexus Medical Technologies investors
43 investors are on record for OtoNexus Medical Technologies, including US National Science Foundation, Impact Assets, MedTech Innovator and Keiretsu Forum. The debt round in Oct 2022 drew 114 investors.
About OtoNexus Medical Technologies
Developer of a medical device designed to diagnose middle ear infections in children and adults. The company's device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in the detection of otitis media, enabling clinicians to identify viral or bacterial infection and determine whether an antibiotic is appropriate.
- Sector
- Healthcare
- HQ
- Bellevue, WA, United States
- Founded
- 2010
- Employees
- 22
- Website
- otonexus.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.